PL327511A1 - Polymorphous forms of a growth hormone secretion stimulating substance - Google Patents

Polymorphous forms of a growth hormone secretion stimulating substance

Info

Publication number
PL327511A1
PL327511A1 PL96327511A PL32751196A PL327511A1 PL 327511 A1 PL327511 A1 PL 327511A1 PL 96327511 A PL96327511 A PL 96327511A PL 32751196 A PL32751196 A PL 32751196A PL 327511 A1 PL327511 A1 PL 327511A1
Authority
PL
Poland
Prior art keywords
growth hormone
hormone secretion
stimulating substance
polymorphous forms
secretion stimulating
Prior art date
Application number
PL96327511A
Other languages
English (en)
Inventor
Jerome P Draper
David C Dubost
Michael J Kaufman
James A Mccauley
Jennifer L Vandrilla
Richard J Varsolona
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9603361.8A external-priority patent/GB9603361D0/en
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of PL327511A1 publication Critical patent/PL327511A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10Spiro-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Fodder In General (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Hydrogenated Pyridines (AREA)
  • Steroid Compounds (AREA)
PL96327511A 1995-10-27 1996-10-23 Polymorphous forms of a growth hormone secretion stimulating substance PL327511A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US590095P 1995-10-27 1995-10-27
GBGB9603361.8A GB9603361D0 (en) 1996-02-16 1996-02-16 Polymorphic forms of a growth hormone secretagogue

Publications (1)

Publication Number Publication Date
PL327511A1 true PL327511A1 (en) 1998-12-21

Family

ID=26308741

Family Applications (1)

Application Number Title Priority Date Filing Date
PL96327511A PL327511A1 (en) 1995-10-27 1996-10-23 Polymorphous forms of a growth hormone secretion stimulating substance

Country Status (22)

Country Link
EP (1) EP1019402A1 (ru)
JP (1) JP3204266B2 (ru)
KR (1) KR19990067098A (ru)
CN (1) CN1067687C (ru)
AU (1) AU707946B2 (ru)
BG (1) BG102476A (ru)
BR (1) BR9611229A (ru)
CA (1) CA2235371A1 (ru)
CO (1) CO4770956A1 (ru)
CZ (1) CZ128098A3 (ru)
EA (1) EA000528B1 (ru)
EE (1) EE9800147A (ru)
HK (1) HK1017894A1 (ru)
HU (1) HUP9902208A3 (ru)
IS (1) IS4721A (ru)
NO (1) NO310556B1 (ru)
NZ (1) NZ321370A (ru)
PL (1) PL327511A1 (ru)
SK (1) SK51398A3 (ru)
TR (1) TR199800726T2 (ru)
WO (1) WO1997015574A1 (ru)
YU (1) YU56696A (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6046333A (en) * 1996-10-25 2000-04-04 Merck & Co., Inc. Convergent process for the preparation of a growth hormone secretagogue
US9119832B2 (en) 2014-02-05 2015-09-01 The Regents Of The University Of California Methods of treating mild brain injury
WO2017075535A1 (en) 2015-10-28 2017-05-04 Oxeia Biopharmaceuticals, Inc. Methods of treating neurodegenerative conditions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK282166B6 (sk) * 1992-12-11 2001-11-06 Merck & Co., Inc. Spiropiperidínové deriváty, spôsob ich výroby a farmaceutický prostriedok s ich obsahom

Also Published As

Publication number Publication date
CO4770956A1 (es) 1999-04-30
AU7468696A (en) 1997-05-15
KR19990067098A (ko) 1999-08-16
HUP9902208A2 (hu) 1999-10-28
EA000528B1 (ru) 1999-10-28
CN1067687C (zh) 2001-06-27
NO981867L (no) 1998-06-29
YU56696A (sh) 1999-09-27
BG102476A (en) 1999-04-30
WO1997015574A1 (en) 1997-05-01
HK1017894A1 (en) 1999-12-03
EA199800335A1 (ru) 1998-12-24
CA2235371A1 (en) 1997-05-01
JP3204266B2 (ja) 2001-09-04
BR9611229A (pt) 1999-05-25
HUP9902208A3 (en) 2001-05-28
NZ321370A (en) 1999-11-29
SK51398A3 (en) 1998-12-02
NO310556B1 (no) 2001-07-23
AU707946B2 (en) 1999-07-22
TR199800726T2 (xx) 1998-08-21
JPH10512295A (ja) 1998-11-24
IS4721A (is) 1998-04-21
EE9800147A (et) 1998-12-15
MX9803351A (es) 1998-09-30
NO981867D0 (no) 1998-04-24
CN1205703A (zh) 1999-01-20
CZ128098A3 (cs) 1998-09-16
EP1019402A1 (en) 2000-07-19

Similar Documents

Publication Publication Date Title
PL327634A1 (en) Growth hormone secretion stimulating compounds
PL338883A1 (en) Growth hormone secretion stimulating compounds
EP0741578A4 (en) HUMAN GROWTH HORMONE
AU682414B2 (en) Stimulation of growth hormone responsive tissues
HUP9900870A3 (en) Composition for sustained release of human growth hormone
ZA968989B (en) Polymorphic forms of a growth hormone secretagogue
PL321590A1 (en) Compounds capable to cause liberation of the growth hormone
PL314003A1 (en) Combination of bisulphonates and substances enhancing secretion of growth hormone
HUP9901718A3 (en) Analogs of parathyroid hormone
HUP9802608A3 (en) Hormone replacement therapy method and hormone dispenser
IL116743A0 (en) Pharmaceutical composition comprising a growth hormone
EP0785784A4 (en) HETEROCYCLIC PIPERIDINES IN POSITION 4 PROMOTING THE RELEASE OF GROWTH HORMONE
AU2931997A (en) Treatment of mood disorders with a growth hormone secretagogue
IL154115A0 (en) Process for the preparation of growth hormone secretagogues
PL326428A1 (en) Method of obtaining a compound stimulating hormonal secretion of a growth hormone
GB9622440D0 (en) Treatment of congestive heart failure with a growth hormone secretagogue
EP0857020A4 (en) FORMULATION OF SECRETAGOGUE STIMULATING THE SECRETION OF THE GROWTH HORMONE, INTENDED TO BE GRANULATED BY WET
GB9602414D0 (en) Camphor compounds promote release of growth hormone
PL327511A1 (en) Polymorphous forms of a growth hormone secretion stimulating substance
AU1942995A (en) New use of growth hormone
IL116742A0 (en) Pharmaceutical composition comprising a growth hormone
ZA954733B (en) Method of controlling pests
EP0796095A4 (en) METHOD FOR INHIBITING THE EFFECTS OF GROWTH HORMONE
IL116741A0 (en) Pharmaceutical composition comprising a growth hormone
AU5881996A (en) Methods of treatment using growth hormone antagonists